Advagen Pharma Limited Issues Drug Recall of 3,684 Bottles

Advagen Pharma Limited issued a drug recall of 3,684 bottles of metoprolol tartrate tablets, USP, 50 mg, after foreign tablets or capsules were found.

Published
1 Min Read
Advagen Pharma Limited Issues Drug Recall of 3,684 Bottles

Advagen Pharma Limited issued a drug recall of 3,684 bottles of metoprolol tartrate tablets, USP, 50-milligram doses, after foreign tablets or capsules were found in the product. The bottles were distributed around the United States, and the company notified customers by letter.

- Advertisement -

The recalled lot is 2611C065A1, and each bottle holds 1,000 tablets with a May 2028 expiration date. The FDA later listed the action in its weekly enforcement report on Nov. 11.

FDA class II listing

The FDA classified the recall as class II, a designation for products that may cause temporary or medically reversible adverse health consequences, or where the chance of serious harm is remote. That classification gives the recall a formal regulatory status, but it does not replace the company’s own notice to customers.

Metoprolol is a beta blocker used by itself or with other drugs to treat high blood pressure and severe chest pain known as angina, and to lower the risk of repeated heart attacks. More than 58 million prescriptions were estimated to have been out for metoprolol in 2024, and nearly 14.6 million people take it.

Advagen Pharma Limited batch 2611C065A1

The recall was initiated on Oct. 27, 2026, before it appeared in the FDA report. That timeline means the affected bottles were already moving through distribution when the enforcement notice made the action publicly visible.

- Advertisement -

Foreign tablets or capsules are the issue the notice identifies, but the recalled information does not say what those materials were or how many bottles may contain them. For customers who received bottles from batch 2611C065A1, the letter is the company’s direct notice, and the FDA listing shows the recall remains part of the agency’s enforcement record.

Advertisement
Share This Article
Senior analyst covering national news, legislative developments, and media trends. Former Washington bureau correspondent with over 14 years experience.